繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

EDAP to Present at Piper Sandler 37th Annual Healthcare Conference

2025-11-18 12:00

EDAP to Present at Piper Sandler 37th Annual Healthcare Conference

Company to Present and Host 1x1 Investor Meetings on Tuesday, December 2nd, 2025

AUSTIN, Texas, November 18, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Chief Executive Officer Ryan Rhodes is scheduled to present and, together with Chief Financial Officer Ken Mobeck, will host 1x1 investor meetings at the upcoming Piper Sandler 37th Annual Healthcare Conference in New York City.

Date:                     Tuesday, December 2nd

Time:                  10:30-10:55 am ET (fireside discussion)

Format:                Fireside discussion and 1x1 investor meetings

Location:               The Lotte New York Palace 

Webcast:              https://event.webcasts.com/starthere.jsp?ei=1743759&tp_key=aa01607b94

The live and archived webcast of the presentation can be accessed in the Investors section of the Company’s website here.        
        

About EDAP TMS SA

A recognized leader in robotic energy-based therapies, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various conditions using ultrasound technology. By combining the latest technologies in imaging, robotics and precise non-invasive energy delivery, EDAP introduced the Focal One® in Europe and in the U.S. as the leading prostate focal therapy controlled by urologists with the potential to expand to multiple indications beyond prostate cancer. For more information on the Company, please visit https://focalone.com/.

Investor Contacts

Investor Relations
EDAP TMS SA
investor.relations@focalone.com

John Fraunces
LifeSci Advisors, LLC
(917) 355-2395
jfraunces@lifesciadvisors.com


風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。